A framework for advancing our understanding of cancer-associated fibroblasts
AffiliationThe Francis Crick Institute, London, UK
MetadataShow full item record
AbstractCancer-associated fibroblasts (CAFs) are a key component of the tumour microenvironment with diverse functions, including matrix deposition and remodelling, extensive reciprocal signalling interactions with cancer cells and crosstalk with infiltrating leukocytes. As such, they are a potential target for optimizing therapeutic strategies against cancer. However, many challenges are present in ongoing attempts to modulate CAFs for therapeutic benefit. These include limitations in our understanding of the origin of CAFs and heterogeneity in CAF function, with it being desirable to retain some antitumorigenic functions. On the basis of a meeting of experts in the field of CAF biology, we summarize in this Consensus Statement our current knowledge and present a framework for advancing our understanding of this critical cell type within the tumour microenvironment.
CitationSahai E, Astsaturov I, Cukierman E, DeNardo DG, Egeblad M, Evans RM, et al. A framework for advancing our understanding of cancer-associated fibroblasts. Nat Rev Cancer. 2020.
JournalNature Reviews Cancer
- Architecture of Cancer-Associated Fibroblasts in Tumor Microenvironment: Mapping Their Origins, Heterogeneity, and Role in Cancer Therapy Resistance.
- Authors: Dzobo K, Dandara C
- Issue date: 2020 Jun
- Cancer associated fibroblasts: phenotypic and functional heterogeneity.
- Authors: Patel AK, Singh S
- Issue date: 2020 Mar 1
- Single-cell analysis on stromal fibroblasts in the microenvironment of solid tumours.
- Authors: Musa M
- Issue date: 2020 Mar
- CAF Subpopulations: A New Reservoir of Stromal Targets in Pancreatic Cancer.
- Authors: Pereira BA, Vennin C, Papanicolaou M, Chambers CR, Herrmann D, Morton JP, Cox TR, Timpson P
- Issue date: 2019 Nov
- Cancer Associated Fibroblasts: The Architects of Stroma Remodeling.
- Authors: Santi A, Kugeratski FG, Zanivan S
- Issue date: 2018 Mar